9:45am - 10:15am Monday, March 9

Location & Room

Orlando - Hyatt Regency
Hyatt - Orlando Ballroom L
Extra Fee

To remain relevant in the eyes of patients, life science companies must redefine and enhance their customer engagement models. The advent of healthcare consumerism has placed more decision making power in the hands of patients and those supporting care outside of traditional healthcare providers.


This session will examine how life sciences can leverage technologies and models used in other industries to transform consumer engagement and meet expectations for more personalized and convenient care.


As speakers will discuss, with the help of technology, life science companies have an opportunity to improve care, reduce the number of patients who discontinue treatments, and eliminate services that do not add value.

Chief Executive Officer,
Navigating Cancer
VP Applied Innovaation and Process Improvement,
Otsuka Pharmaceuticals
Director of Reproductive Health,
Ferring Pharmaceutical
Worldwide Lead Healthcare, Life Sciences, Genomics,
Amazon Web Services
Life Science Business Lead,